Speakers
Nathan Magarvey
Founder
Adapsyn Bioscience
Nigel Titford
CEO
Biogaia Pharma
Adrien Nivoliez
CEO
Biose Industrie
Assaf Oron
Chief Business Officer
BiomX
Chris Reyes
Co-Founder & CEO
Bloom Science
Jeffrey Heiser
Director Microbiology
Boston Analytical
Helena Cowley
CEO
Captozyme
Mark Pimentel MD
Director of MAST Program
Cedars-Sinai
Ben Bradley
Head of Partnerships & Licensing
CHAIN Biotech
John Colson
Director of Operations
ClostraBio
Greg Mckenzie
Chief Scientific Officer
ConsortiaTX
Nur Hasan
Chief Scientific Officer
CosmosID
Dan Knights
CEO
CoreBiome
Gerard Honig
Translational Research Manager
Crohn’s & Colitis Foundation
Julia Cope
Director of Scientific Operations
Diversigen
Mark Smith
CEO
Finch Therapeutics Group
Ulrich Thienel
Chief Medical Officer
Finch Therapeutics Group
Kris Piper
VP Regulatory Affairs
Finch Therapeutics Group
Bharat Dixit
VP Bioprocess & Analytical Development
Finch Therapeutics Group
Daniel van der Lelie
Chief Scientific Officer
Gusto Global
Esi Lamouse-Smith
Director - Early Development Translational Medicine in Immunology
Janssen Pharmaceuticals
Ling-Yang Hao
Associate Director
Janssen Pharmaceuticals
Karen Crawford
President
List Laboratories
Tina Chritensen-Ram
Quality Manager
LuinaBio
Mark Wilson
President & CEO
MatriSys Bioscience
Lynn Bry MD
Director
Massachusetts Host-Microbiome Center
Malcolm Kendall
CEO
Microbiome Insights
Mike Romanos
CEO
Microbiotica
Trevor Lawley
Chief Scientific Officer
Microbiotica
Julius Goepp
CEO
Scaled Microbiomics
Herwig Bachmann
Group Leader Fermentation
NIZO
Wes Whitaker
Co-Founder & CEO
Novome Biotechnologies
Liz Shepherd
Co-Founder
Novome Biotechnologies
Massimo Marzorati
CEO
ProDigest
Sam Possemiers
Managing Director
ProDigest
Mike Frodsham
Pharmaceutical Development Manager
Quay Pharma
Matthew Henn
EVP Microbiome R&D
Seres Therapeutics
Jim Weston
SVP Regulatory Affairs
Seres Therapeutics
Jennifer Wortman
Senior Director, Bioinformatics
Seres Therapeutics
Henry Rath
SVP Corporate Development
Seres Therapeutics
Nikole Kimes
Founder & Chief Scientific Officer
Siolta Therapeutics
Gregory Lambert
CEO
TargEDys
Cathryn Nagler
Bunning Food Allergy Professor
University of Chicago
Rita Colwell
Distinguished University Professor
University of Maryland
Alexander Khoruts MD
Medical Director
University of Minnesota Microbiota Therapeutics
Colleen Cutcliffe
Co-Founder & CEO
Whole Biome
Andrew Goodman
Associate Professor
Yale University
Bernat Olle
CEO
Vedanta Biosciences
Ross Youngs
CEO & Founder
Biosortia Pharmaceuticals
Suguna Rachakonda
Senior Director, Product Development
Cleveland Clinic
Romain Daillere
Co-Founder & Head of Preclinical Research
EverImmune
Dario Gutierrez
Head of Investigational Biology
Merck ESC
Daniel van der Lelie
Chief Scientific Officer
Gusto Global
Fyza Shaikh
Postdoctoral Fellow
John Hopkins Hospital
Ashwin Ananthakrishnan MD
Associate Professor of Medicine
Massachusetts General Hospital
Edward Burd
Head of Regulatory Affairs
Rebiotix
Matt Martin
Microbiome Lead Technology Commercialization
University of Chicago
Speaker Invited
FDA
David Cook
EVP & Chief Scientific Officer
Seres Therapeutics
Thomas J. DesRosier
Chief Legal Officer & Secretary
Seres Therapeutics
Glennda Smithson
Director, Translational Biomarker Research (Immunology)
Takeda
Eric Shaff
CEO
Seres Therapeutics
Alison Lawton
CEO
Kaleido Biosciences
Tuval Ben-Yehezkel
CEO
Loop Genomics
Katharine Knobil MD
Chief Medical Officer & Head of R&D
Kaleido Biosciences
Susan Stewart
SVP, Regulatory Affairs & Quality
Kaleido Biosciences
James McIlroy
Founder & Chief Business Officer
Enterobiotix
Lothar Steidler
Chief Technology Officer
ActoBio Therapeutics
Stacy Burns-Guydish
VP, Biotherapeutics Development & Manufacturing
List Laboratories
Ken Blount
CSO
Rebiotix